Corneal implants Market By Procedure Type (Penetrating keratoplasty, Endothelial keratoplasty, Others), By Disease Type (Keratoconus, Fuchs' dystrophy, Infectious keratitis, Others), By End User (Hospitals, Ophthalmic centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global corneal implant market was valued at $1,264.18 million in 2021, and is projected to reach $2,124.44 million by 2031, registering a CAGR of 5.3% from 2022 to 2031.
The outermost translucent portion of the eyeball's covering known as the cornea protects the iris and pupil while allowing light to enter the interior. It directs and concentrates light as it enters the eye. Between 65 and 75 percent of the eye's entire focusing power comes from the cornea.
A corneal transplant involves replacing a cloudy cornea with a clear donor cornea. Donor tissue comes from individuals who have donated their eyes for the benefit of others. The donor corneas used in transplants are kept freshly stored in eye banks. Furthermore, artificial cornea is an option for transplant patients who cannot tolerate a human donor cornea. In order to correct vision issues caused by various ocular disorders, corneal transplants are typically performed.
The global corneal implant market is expected to witness a substantial growth in the future, owing to surge in prevalence of eye diseases such as Fuchs’ dystrophy, keratoconus keratitis, corneal scarring, corneal ulcers and corneal edema. People suffering from these ocular diseases need corneal transplantation on the basis of severity of diseases.
Furthermore, rise in incidences of corneal blindness is the primary factor that drives the growth of the cornea implant market. For instance, according to the SightLife organization more than 12.7 million people globally suffer from corneal blindness. Thus, rise in incidences of corneal blindness is the primary factor that drives the growth of the cornea implant market. In addition, increase in incidences of trauma cases lead to high chances of eye injury, which further propel the market growth.
Moreover, technological advancements in the development of the artificial cornea propel the market growth. Various key market players are involved in the development of the bioengineered artificial corneal implant which further drives the demand of the corneal implants subsequently flourish the market growth.
Furthermore, growth opportunities in emerging markets contribute towards the growth of the market. Availability of improved healthcare industry infrastructure, growth in number of pharmaceutical industries, and surge in incidence of the corneal disorders drives the growth of the market in emerging economies. However, low availability of human cornea donors and high risk in the grafting artificial cornea implant is expected to impede the market growth during the forecast period. Conversely, rise in geriatric population is a lucrative opportunity for the market growth. As the geriatric population is more susceptible to corneal diseases.
The global corneal implant market is segmented into type, disease type, transplant type, end user, and region. On the basis of disease type, the market is segregated into keratoconus, Fuchs’ dystrophy, infectious keratitis and others. On the basis of transplant type, market is segmented into penetrating keratoplasty, anterior lamellar keratoplasty, endothelial keratoplasty and keratoprothesis. On the basis of end user, the market is categorized into hospitals, ambulatory surgical centers and ophthalmic centers. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global corneal implant market are Corneagen, Presbia Plc, Presbia Plc, mediphacos, Aurolab, AJL Opthalmic SA, LinkoCare Life Sciences AB, DIOPTEX, EyeYon Medical, and KeraMed, Inc.
Key Benefits For StakeholdersThis report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the corneal implants market analysis from 2021 to 2031 to identify the prevailing corneal implants market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the corneal implants market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global corneal implants market trends, key players, market segments, application areas, and market growth strategies.
Key Market SegmentsBy Procedure TypePenetrating keratoplasty
Endothelial keratoplasty
Others
By Disease TypeKeratoconus
Fuchs' dystrophy
Infectious keratitis
Others
By End UserHospitals
Ophthalmic centers
Others
By RegionNorth America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Presbia Plc
CorNeat Vision
Aurolab
AJL Opthalmic SA
LinkoCare Life Sciences AB
CorneaGen
DIOPTEX
Mediphacos
EyeYon Medical
KeraMed, Inc
Please Note: It will take 7-10 business days to complete the report upon order confirmation.